Secondary outcomes included body weight (BW), waist circumference (WC), insulin levels, glycated haemoglobin (HbA1c), homeostatic model assessment of insulin resistance (HOMA-IR), aspartate aminotransferase (AST), and alanine aminotransferase (ALT). The gene discussed is INS; the disease is Insulin resistance.